BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34519725)

  • 41. In vitro study of the trypanocidal activity of anilinophenanthrolines against Trypanosoma cruzi.
    Zuma AA; da Silva RB; Garden SJ; de Souza W
    Parasitol Int; 2021 Aug; 83():102338. PubMed ID: 33766741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection.
    Cuevas-Hernández RI; Girard RMBM; Krstulović L; Bajić M; Silber AM
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009994. PubMed ID: 34843481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
    Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
    J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
    DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
    Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
    Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues.
    Silva FT; Franco CH; Favaro DC; Freitas-Junior LH; Moraes CB; Ferreira EI
    Eur J Med Chem; 2016 Oct; 121():553-560. PubMed ID: 27318979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.
    da Silva CF; Batista MM; Batista Dda G; de Souza EM; da Silva PB; de Oliveira GM; Meuser AS; Shareef AR; Boykin DW; Soeiro Mde N
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3307-14. PubMed ID: 18625779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
    Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
    ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity.
    Martinez-Peinado N; Cortes-Serra N; Torras-Claveria L; Pinazo MJ; Gascon J; Bastida J; Alonso-Padilla J
    Parasit Vectors; 2020 Jun; 13(1):299. PubMed ID: 32522289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase.
    Vieites M; Smircich P; Parajón-Costa B; Rodríguez J; Galaz V; Olea-Azar C; Otero L; Aguirre G; Cerecetto H; González M; Gómez-Barrio A; Garat B; Gambino D
    J Biol Inorg Chem; 2008 Jun; 13(5):723-35. PubMed ID: 18322709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases.
    Cunha Almeida T; Gonzaga Ribeiro LH; Ferreira Dos Santos LB; da Silva CM; Tupinambá Branquinho R; de Lana M; Ramos Gadelha F; de Fátima Â
    Biomed Pharmacother; 2018 Dec; 108():1703-1711. PubMed ID: 30372873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
    Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound.
    Mosquillo MF; Bilbao L; Hernández F; Tissot F; Gambino D; Garat B; Pérez-Díaz L
    Chem Biol Drug Des; 2018 Sep; 92(3):1657-1669. PubMed ID: 29745031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiparasitic effect of (-)-α-bisabolol against Trypanosoma cruzi Y strain forms.
    de Menezes RRPPB; Sampaio TL; Lima DB; Sousa PL; de Azevedo IEP; Magalhães EP; Tessarolo LD; Marinho MM; Dos Santos RP; Martins AMC
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114860. PubMed ID: 31353066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
    Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, México.
    Domínguez-Díaz LR; Eugenia Ochoa M; Soto-Castro D; Farfán N; Morales-Chamorro M; Yépez-Mulia L; Pérez-Campos E; Santillan R; Moreno-Rodríguez A
    Bioorg Med Chem; 2021 Oct; 48():116417. PubMed ID: 34571489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zinc 1,2,4-triazolo[1,5-a]pyrimidine Complexes: Synthesis, Structural Characterization and their Effect Against Chagas Disease.
    Méndez-Arriaga JM; Rubio-Mirallas E; Quirós M; Sánchez-Moreno M
    Med Chem; 2022; 18(4):444-451. PubMed ID: 34387166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.